Liquid Biopsy Market Forecast, Manufacture Size, Developments and Future Scope To 2025 Market Research Engine has published a new report titled as “Liquid Biopsy Market Size By Application (Non-Cancer Applications, Cancer Applications), By End User (Academic and Research Centers, Hospitals and Physician Laboratories, Reference Laboratories, Other End Users), By Clinical Application (Early Cancer Screening, Recurrence Monitoring, Treatment Monitoring, Therapy Selection), By Product and Service (Instruments, Services, Assay Kits), By Circulating Biomarker (Extracellular Vesicles, Circulating Tumor Cells, Circulating Tumor Dna, Cell-Free Dna, Other Circulating Biomarkers), By Technology (Single Gene Analysis Using Pcr Microarrays, Multi-Gene-Parallel Analysis Using Ngs), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2020-2025.�
A liquid biopsy is fast ahead traction as a supplement or alternate to doing a tissue biopsy for applications in procreative health, cancer, and transplant medicine. The liquid biopsy techniques agree the physicians to comprehend the critical nature of the disease after the finding and screening procedure. The main biomarker kinds used in liquid biopsy contain circulating cellfree nucleic acids. Extracellular vesicles are a varied class of lipid-bound elements shed by any cell in the body in pathological and physiological conditions. Microarray technology has been widely used in cancer research for more than a period. Droplet Digital PCR agrees for the detection of target sequences which are contemporary in the very low background against other sequences present at high concentrations. Proteomics platforms include Mass Spectrometry and biochips. Deficiency of consensus on Standard Operating Measures and poor compensation structures are some of the main factors hindering the global liquid biopsy market. The compensation and treatment monitoring for liquid biopsy is limited, and it is achieved in a few laboratories. The poor reimbursement system is a important restraint which restricts the individuals to go for cancer detection tests and affects cancer biomarkers market negatively. Browse Full Report: https://www.marketresearchengine.com/liquid-biopsymarket-report
The global Liquid Biopsy market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Liquid Biopsy market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others. Competitive Rivalry Mdxhealth SA, Genomic Health, Inc., Raindance Technologies, Inc, Thermo Fisher Scientific Inc., Illumina, Inc., Biocept, Inc, Qiagen N.V., Roche Diagnostics, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc, and others are among the major players in the global Liquid Biopsy market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Liquid Biopsy Market has been segmented as below: Liquid Biopsy Market, By Application
Non-Cancer Applications
Cancer Applications
Liquid Biopsy Market, By End User
Academic and Research Centers
Hospitals and Physician Laboratories
Reference Laboratories
Other End Users
Liquid Biopsy Market, By Clinical Application
Early Cancer Screening
Recurrence Monitoring
Treatment Monitoring
Therapy Selection
Liquid Biopsy Market, By Product and Service
Instruments
Services
Assay Kits
Liquid Biopsy Market, By Circulating Biomarker
Extracellular Vesicles
Circulating Tumor Cells
Circulating Tumor Dna
Cell-Free Dna
Other Circulating Biomarkers
Liquid Biopsy Market, By Technology
Single Gene Analysis Using Pcr Microarrays
Multi-Gene-Parallel Analysis Using Ngs
Liquid Biopsy Market, By Region
North America
Europe
Asia-Pacific
Rest of the World
Liquid Biopsy Market, By Company
Mdxhealth SA
Genomic Health, Inc.
Raindance Technologies, Inc
Thermo Fisher Scientific Inc.
Illumina, Inc.
Biocept, Inc
Qiagen N.V.
Roche Diagnostics
Bio-Rad Laboratories, Inc.
Myriad Genetics, Inc
Menarini-Silicon Biosystems
Trovagene, Inc.
Guardant Health, Inc.
The report covers:
Global Liquid Biopsy market sizes from 2015 to 2024, along with CAGR for 2019-2025
Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2025
Global Liquid Biopsy market trends, covering comprehensive range of consumer trends & manufacturer trends
Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Liquid Biopsy market
Major market opportunities and challenges in forecast timeframe to be focused
Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
Comprehensive company profiles of the key industry players
Report Scope: The global Liquid Biopsy market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Liquid Biopsy market share. Major industry players with significant revenue share include Mdxhealth SA, Genomic Health, Inc., Raindance Technologies, Inc, Thermo Fisher Scientific Inc., Illumina, Inc., Biocept, Inc, Qiagen N.V., Roche Diagnostics, BioRad Laboratories, Inc., Myriad Genetics, Inc, and others. Reasons to Buy this Report:
Gain detailed insights on the Liquid Biopsy industry trends
Find complete analysis on the market status
Identify the Liquid Biopsy market opportunities and growth segments
Analyse competitive dynamics by evaluating business segments & product portfolios
Facilitate strategy planning and industry dynamics to enhance decision making
Some of the recent developments in Liquid Biopsy Market are as follows: Mdxhealth SA
10-2019: MDxHealth is a multinational healthcare company which offers actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer.
27-2018: MDxHealth SA declared the publication of positive data demonstrating the value of the SelectMDx liquid biopsy test for Prostate Cancer in guiding patient management for men being considered for multiparametric MRI and the clinical utility in guiding biopsy decisions in real-world clinical practice.
Genomic Health, Inc.
09-2014: Genomic Health, Inc. declared positive results from its first two feasibility studies assessing multiple technologies, including next-generation sequencing, for their ability to detect and characterize the presence of bladder cancer DNA in urine and breast cancer DNA in blood.
11-2016: Genomic Health, Inc. declared plans to launch its first liquid biopsy test.
Customization Customized report as per the requirement can be offered with appropriate recommendations Request Sample Report from here: https://www.marketresearchengine.com/liquid-biopsy-market-report Table of Contents:
1. Introduction 1.1 Key Insights 1.2 Report Overview 1.3 Markets Covered 1.4 Stakeholders 2. Research Methodology 2.1 Research Scope 2.2 Market Research Process 2.3 Research Data Analysis
2.4.1 Secondary Research 2.4.2 Primary Research 2.4.3 Models for Estimation 2.5 Market Size Estimation 2.5.1 Bottom-Up Approach - Segmental Market Analysis 2.5.2 Top-Down Approach - Parent Market Analysis 3. Executive Summary 4. Market Overview 4.1 Introduction 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.2.4 Challenges 4.2 Porter's Five Force Analysis
5. Liquid Biopsy Market, By Application 5.1 Introduction 5.2 Non-Cancer Applications 5.2.1 Market Overview 5.2.2 Market Size and Forecast 5.3 Cancer Applications 5.3.1 Market Overview 5.3.2 Market Size and Forecast 6. Liquid Biopsy Market, By End User 6.1 Introduction 6.2 Academic and Research Centers 6.2.1 Market Overview 6.2.2 Market Size and Forecast 6.3 Hospitals and Physician Laboratories 6.3.1 Market Overview 6.3.2 Market Size and Forecast 6.4 Reference Laboratories 6.4.1 Market Overview 6.4.2 Market Size and Forecast 6.5 Other End Users 6.5.1 Market Overview 6.5.2 Market Size and Forecast 7. Liquid Biopsy Market, By Clinical Application 7.1 Introduction 7.2 Early Cancer Screening
7.2.1 Market Overview 7.2.2 Market Size and Forecast 7.3 Recurrence Monitoring 7.3.1 Market Overview 7.3.2 Market Size and Forecast 7.4 Treatment Monitoring 7.4.1 Market Overview 7.4.2 Market Size and Forecast 7.5 Therapy Selection 7.5.1 Market Overview 7.5.2 Market Size and Forecast 8. Liquid Biopsy Market, By Product and Service 8.1 Introduction 8.2 Instruments 8.2.1 Market Overview 8.2.2 Market Size and Forecast 8.3 Services 8.3.1 Market Overview 8.3.2 Market Size and Forecast 8.4 Assay Kits 8.4.1 Market Overview 8.4.2 Market Size and Forecast 9. Liquid Biopsy Market, By Circulating Biomarker 9.1 Introduction 9.2 Extracellular Vesicles 9.2.1 Market Overview 9.2.2 Market Size and Forecast 9.3 Circulating Tumor Cells 9.3.1 Market Overview 9.3.2 Market Size and Forecast 9.4 Circulating Tumor Dna 9.4.1 Market Overview 9.4.2 Market Size and Forecast 9.5 Cell-Free Dna 9.5.1 Market Overview 9.5.2 Market Size and Forecast 9.6 Other Circulating Biomarkers 9.6.1 Market Overview 9.6.2 Market Size and Forecast 10. Liquid Biopsy Market, By Technology 10.1 Introduction 10.2 Single Gene Analysis Using Pcr Microarrays 10.2.1 Market Overview
10.2.2 Market Size and Forecast 10.3 Multi-Gene-Parallel Analysis Using Ngs 10.3.1 Market Overview 10.3.2 Mrket Size and Forecast 11. Liquid Biopsy Market, By Geography 11.1 Introduction 11.2 North America 11.2.1 North America Liquid Biopsy, By Application 11.2.2 North America Liquid Biopsy, By End User 11.2.3 North America Liquid Biopsy, By Clinical Application 11.2.4 North America Liquid Biopsy, By Product and Service 11.2.5 North America Liquid Biopsy, By Circulating Biomarker 11.2.6 North America Liquid Biopsy, By Technology 11.3 Europe 11.3.1 Europe Liquid Biopsy, By Application 11.3.2 Europe Liquid Biopsy, By End User 11.3.3 Europe Liquid Biopsy, By Clinical Application 11.3.4 Europe Liquid Biopsy, By Product and Service 11.3.5 Europe Liquid Biopsy, By Circulating Biomarker 11.3.6 Europe Liquid Biopsy, By Technology 11.4 Asia-Pacific 11.4.1 Asia-Pacific Liquid Biopsy, By Application 11.4.2 Asia-Pacific Liquid Biopsy, By End User 11.4.3 Asia-Pacific Liquid Biopsy, By Clinical Application 11.4.4 Asia-Pacific Liquid Biopsy, By Product and Service 11.4.5 Asia-Pacific Liquid Biopsy, By Circulating Biomarker 11.4.6 Asia-Pacific Liquid Biopsy, By Technology 11.5 Rest of the World 11.5.1 Rest of the World Liquid Biopsy, By Application 11.5.2 Rest of the World Liquid Biopsy, By End User 11.5.3 Rest of the World Liquid Biopsy, By Clinical Application 11.5.4 Rest of the World Liquid Biopsy, By Product and Service 11.5.5 Rest of the World Liquid Biopsy, By Circulating Biomarker 11.5.6 Rest of the World Liquid Biopsy, By Technology 12. Competitive Insights 12.1 Key Insights 12.2 Company Market Share Analysis 12.3 Strategic Outlook 12.3.1 Mergers & Acquisitions 12.3.2 New Product Development 12.3.3 Portfolio/Production Capacity Expansions 12.3.4 Joint Ventures, Collaborations, Partnerships & Agreements 12.3.5 Others 13. Company Profiles 13.1 Mdxhealth SA
13.1.1 Company Overview 13.1.2 Product/Service Landscape 13.1.3 Financial Overview 13.1.4 Recent Developments 13.2 Genomic Health, Inc. 13.2.1 Company Overview 13.2.2 Product/Service Landscape 13.2.3 Financial Overview 13.2.4 Recent Developments 13.3 Raindance Technologies, Inc 13.3.1 Company Overview 13.3.2 Product/Service Landscape 13.3.3 Financial Overview 13.3.4 Recent Developments 13.4 Thermo Fisher Scientific Inc. 13.4.1 Company Overview 13.4.2 Product/Service Landscape 13.4.3 Financial Overview 13.4.4 Recent Developments 13.5 Illumina, Inc. 13.5.1 Company Overview 13.5.2 Product/Service Landscape 13.5.3 Financial Overview 13.5.4 Recent Developments 13.6 Biocept, Inc 13.6.1 Company Overview 13.6.2 Product/Service Landscape 13.6.3 Financial Overview 13.6.4 Recent Developments 13.7 Qiagen N.V. 13.7.1 Company Overview 13.7.2 Product/Service Landscape 13.7.3 Financial Overview 13.7.4 Recent Developments 13.8 Roche Diagnostics 13.8.1 Company Overview 13.8.2 Product/Service Landscape 13.8.3 Financial Overview 13.8.4 Recent Developments 13.9 Bio-Rad Laboratories, Inc. 13.9.1 Company Overview 13.9.2 Product/Service Landscape 13.9.3 Financial Overview 13.9.4 Recent Developments 13.10 Myriad Genetics, Inc 13.10.1 Company Overview
13.10.2 Product/Service Landscape 13.10.3 Financial Overview 13.10.4 Recent Developments 13.11 Menarini-Silicon Biosystems 13.11.1 Company Overview 13.11.2 Product/Service Landscape 13.11.3 Financial Overview 13.11.4 Recent Developments 13.12 Trovagene, Inc. 13.12.1 Company Overview 13.12.2 Product/Service Landscape 13.12.3 Financial Overview 13.12.4 Recent Developments 13.13 Guardant Health, Inc 13.13.1 Company Overview 13.13.2 Product/Service Landscape 13.13.3 Financial Overview 13.13.4 Recent Developments
Other Related Market Research Reports: Image Sensor Market Global Opportunity Analysis and Industry Forecast 20202025 LMS Market Global Opportunity Analysis and Industry Forecast 2020-2025 Nutraceutical Ingredients Market Global Opportunity Analysis and Industry Forecast 2020-2025 About MarketResearchEngine.com Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies. Media Contact Company Name: Market Research Engine Contact Person: John Bay Email: john@marketresearchengine.com Phone: +1-855-984-1862
Country: United States Website: https://www.marketresearchengine.com/ Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States